HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-01-14FDA Approved: NEVIRAPINE — Original Application (Macleods Pharmaceuticals Limited)
FDA approves the original generic application for Nevirapine from Macleods Pharmaceuticals Limited for treatment of HIV infection.
-
CLINICAL_TRIALS trial_result · 2019-01-03Clinical Trial Update: Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients [Phase 2]
Phase 2 trial assessing safety and immunogenicity of IMVAMUNE (MVA-BN) smallpox vaccine in HIV-infected individuals has completed with resul…
-
CLINICAL_TRIALS trial_result · 2018-12-31Clinical Trial Update: Raltegravir Versus Efavirenz in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis [Phase 3]
Phase 3 trial comparing raltegravir to efavirenz in ART-naive HIV-1 patients on rifampin for active tuberculosis; completed status ongoing r…
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: HIV Protease Inhibitors for the Prevention of Malaria in Ugandan Children [Phase 3]
Phase 3 trial evaluating HIV protease inhibitors for prevention of malaria in Ugandan children has completed with results posted.
-
CLINICAL_TRIALS research · 2018-12-28Clinical Trial Update: A Study to Investigate the Influence of Hepatic Insufficiency on the Pharmacokinetics of Doravirine (MK-1439) (MK-1439-019) [Phase 1]
A Phase 1 trial evaluated how hepatic insufficiency affects the pharmacokinetics of doravirine (MK-1439).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-12-28Clinical Trial Update: Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men [NA]
Completed clinical trial evaluating a structural and behavioral HIV risk reduction program for Black men; results posted in 2018.
-
CLINICAL_TRIALS withdrawal · 2018-12-26Clinical Trial Update: The Use of Nutropin Depot in HIV-infected Adult Males [Phase 2, Phase 3]
Clinical trial update for Nutropin Depot in HIV-infected adult males shows the study has been withdrawn after Phase 2/3.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial [Phase 2]
Phase 2 long-term follow-up of OZ1 gene therapy in HIV-1 patients has completed, with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-12-12Clinical Trial Update: The Health Check-Up for Expectant Moms [NA]
A completed clinical trial studying health check-ups for expectant mothers with HIV; results posted in 2018.
-
FDA approval · 2018-12-11FDA Approved: VIREAD — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for VIREAD (tenofovir disoproxil fumarate) submitted by Gilead Sciences, Inc.
-
FDA approval · 2018-12-10FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
FDA approved a supplemental application for EMTRIVA (emtricitabine) from Gilead Sciences, resulting in a labeling update or expanded use und…
-
FDA approval · 2018-12-10FDA Approved: EMTRIVA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for EMTRIVA (emtricitabine) submitted by Gilead Sciences, Inc.
-
CLINICAL_TRIALS trial_result · 2018-12-10Clinical Trial Update: Effects of Contraceptive Ring on Vaginal Microbiota, HIV Shedding and Local Immunity [Phase 4]
Phase 4 trial assessing the effects of a contraceptive ring on vaginal microbiota, HIV shedding, and local immunity in bacterial vaginosis a…
-
CLINICAL_TRIALS trial_result · 2018-12-06Clinical Trial Update: Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) [Phase 3]
Phase 3 clinical trial BRIEF TB evaluating rifapentine-isoniazid for tuberculosis prevention has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2018-11-28Clinical Trial Update: Gender-Affirmative Transgender Care to Improve the HIV Treatment Cascade [Phase 4]
Phase 4 clinical trial evaluating gender-affirmative transgender care and its impact on improving the HIV treatment cascade in people with H…
-
CLINICAL_TRIALS research · 2018-11-20Clinical Trial Update: SteadyRx: Smartphone ART Adherence Intervention for Drug Users [NA]
A completed clinical trial evaluating SteadyRx, a smartphone-based ART adherence intervention for people with HIV, with results posted in 20…
-
FDA approval · 2018-11-15FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA issued a supplemental approval for Kaletra (lopinavir/ritonavir) submitted by AbbVie.
-
FDA approval · 2018-11-15FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie. The approval updates the product under the NDA, potentia…
-
FDA approval · 2018-11-15FDA Approved: NORVIR — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Norvir (ritonavir) submitted by AbbVie.
-
FDA approval · 2018-11-15FDA Approved: ABACAVIR AND LAMIVUDINE — Original Application (Aurobindo Pharma Limited)
FDA approved a fixed-dose combination generic tablet of abacavir and lamivudine via an original ANDA from Aurobindo Pharma Limited for HIV-1…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections [Phase 2]
Phase 2 clinical trial update for an HIV attachment inhibitor intended to treat HIV-1 infections; results have been posted with completion i…
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Dolutegravir Antiretroviral Strategy to Promote Improvement and Reduce Drug Exposure [Phase 3]
Phase 3 trial evaluating a dolutegravir-based antiretroviral strategy to improve outcomes and reduce drug exposure in HIV infection.
-
CLINICAL_TRIALS trial_result · 2018-11-13Clinical Trial Update: Study to Evaluate the Efficacy of MONotherapy of TiviCAY® Versus a Triple Therapy in HIV-1-infected Patients [Phase 3]
A Phase 3 clinical trial evaluating monotherapy with TiviCAY versus a triple therapy in HIV-1-infected patients was terminated.
-
CLINICAL_TRIALS trial_result · 2018-11-09Clinical Trial Update: Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants [Phase 3]
Phase 3 trial comparing a darunavir/cobicistat/emtricitabine/tenofovir alafenamide regimen to a boosted protease inhibitor regimen with emtr…
-
FDA approval · 2018-11-09FDA Approved: EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's generic fixed-dose combination efavirenz/emtricitabine/tenofovir disoproxil fumarate for HIV-1 infection.